By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Shares of Agilent Technologies rose more than 8 percent on Friday, a day after company officials increased its operating margin and return on invested capital goals under its operating model.
Registering provides access to this and other free content.
Already have an account?Login Now.
A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.
NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.
In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.
Hong Kong is using DNA phenotyping to shame litterers.